These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3548129)

  • 1. [Tumor-associated macrophage subpopulation and the prolific activity of malignant tumors--an immunohistochemical study of 109 breast carcinomas].
    Müller H; Hashimoto H; Stutte HJ
    Verh Dtsch Ges Pathol; 1986; 70():251-6. PubMed ID: 3548129
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma.
    Papsidero LD; Croghan GA; O'Connell MJ; Valenzuela LA; Nemoto T; Chu TM
    Cancer Res; 1983 Apr; 43(4):1741-7. PubMed ID: 6339043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies.
    Dell'Erba L; Calo-Gabrieli G; Caruso ML; Thomas R; Cortino G; Valentini AM; Muto P; Albrizio M; Pastena MI; Lastoria S
    Anticancer Res; 2001; 21(2A):925-30. PubMed ID: 11396186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of normal and tumor-associated antigens in human breast carcinoma.
    Sawtell NM; DiPersio L; Michael JG; Pesce AJ; Weiss MA
    Lab Invest; 1984 Aug; 51(2):225-32. PubMed ID: 6087025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM; Steck PA; Nicolson GL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of immunohistochemical probes in the study of benign and malignant breast disease.
    Gusterson BA; Warburton MJ; Monaghan P; Foster C; Edwards P; Kraft N; Smith C; Mitchell D; Rudland PS; Neville AM
    Behring Inst Mitt; 1984 May; (74):39-48. PubMed ID: 6383328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M; Castagna M; Squartini F
    Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical estimation of the proliferative action of breast and large intestine carcinomas].
    Horny HP; Horst HA
    Verh Dtsch Ges Pathol; 1986; 70():262-8. PubMed ID: 3548131
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomorphological study of human tumors using the monoclonal antibody RMZh-1].
    Kulevich EE; Sedel'nikova OA; Petrovichev NN; Chistiakova OV
    Arkh Patol; 1993; 55(2):6-8. PubMed ID: 7526832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in surface antigen expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinomas, and breast carcinomas.
    Ceriani RL; Peterson JA; Blank EW
    Cancer Res; 1984 Jul; 44(7):3033-9. PubMed ID: 6144385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies.
    Rasmussen BB; Pedersen BV; Thorpe SM; Hilkens J; Hilgers J; Rose C
    Cancer Res; 1985 Mar; 45(3):1424-7. PubMed ID: 3971385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a cell-surface antigen (LEA.135) associated with favorable prognosis in human breast cancer.
    Imam SA; Esteban EF; Chen RS; Cardiff RD; Taylor CR
    Cancer Res; 1993 Jul; 53(14):3233-6. PubMed ID: 7686814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface membrane heterogeneity among human mononuclear phagocytes.
    Biondi A; Rossing TH; Bennett J; Todd RF
    J Immunol; 1984 Mar; 132(3):1237-43. PubMed ID: 6198386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of rat thymic macrophages. Phenotypic characterization and possible relationships between different cell subsets.
    Vicente A; Varas A; Moreno J; Sacedón R; Jiménez E; Zapata AG
    Immunology; 1995 May; 85(1):99-105. PubMed ID: 7635528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to detect markers specific for tumors.
    Klavins JV
    Ann Clin Lab Sci; 1987; 17(4):221-5. PubMed ID: 3619397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
    Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
    Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody (AB/3) reactive with human breast cancer.
    Iacobelli S; Natoli V; Scambia G; Santeusanio G; Negrini R; Natoli C
    Cancer Res; 1985 Sep; 45(9):4334-8. PubMed ID: 3896478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibition factor test in breast tumors.
    Gutman H; Kott I; Rabinerson D; Reiss R
    Isr J Med Sci; 1986 Nov; 22(11):812-6. PubMed ID: 3793437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.